Risk factors

Generates over 75% of revenue from US healthcare providers through paging and software solutions. Faces ongoing subscriber erosion in its legacy wireless business requiring network rationalization. Relies heavily on R&D, long sales cycles, and third-party vendors for paging equipment.

Company is a clinical-stage biopharmaceutical firm reliant on pipeline candidates apitegromab and SRK-181.

Capella University and Strayer University depend heavily on Title IV federal student financial aid programs and face extensive regulation. International expansion into Australia and New Zealand introduces complex integration and operational risks.

Starwood Property Trust’s risk profile is dominated by significant exposure to commercial real estate sectors like office space, heavy reliance on external management by Starwood Capital Group with potential conflicts of interest, and extensive use of high leverage and debt financing.

The company faces primary risks from interest rate volatility, deposit pricing pressure, and credit quality fluctuations in its loan portfolio.

This company has no prior year filing and is dominated by risks of capital requirements, clinical trials, and intellectual property protection.

Volatility in oil and natural gas prices directly impacts operational growth, cash flow, and credit facility borrowings. Geographic concentration in the U.S. Gulf of America and Mexico increases vulnerability to regional disruptions. Operations depend heavily on non-operated assets like the Zama Field, limiting direct operational control.

Credit losses and falling valuations in private middle-market investments are the central risks.

Teladoc faces massive cumulative net losses, including a $790 million goodwill impairment in 2024. BetterHelp marketing costs and customer acquisition are critical to revenue. Heavy regulatory, state legal, and healthcare compliance burdens threaten virtual care expansion.

Tidewater's risks are dominated by heavy exposure to cyclical oil and gas markets, global offshore operations, and strict regulatory compliance.

Thryv faces intense competition for its SaaS and Marketing Services offerings across the SMB market. The company reported a net loss of $74.2 million for the year ended December 31, 2024. Transitioning legacy print and digital clients to the SaaS Thryv Platform creates significant operational and churn risks. Heavy reliance on third-party vendors and search engines exposes the business to technological and search algorithm disruptions.

TransMedics relies heavily on customer adoption of its NOP platform and availability of donor organs. The company operates its own growing fleet of fixed-wing aircraft, introducing aviation and fuel cost risks. Significant debt obligations include $60.0 million in long-term debt and $460.0 million in convertible notes.